WednesdayJun 18, 2014 9:18 am

Colt Resources (COLTF) On Track in Mineral-Rich Portugal

Colt Resources’ attention is focused on its 534,000 acres of Experimental Mining License and Exploration Concession high-grade gold and tungsten projects in Portugal which includes the 11,000 acre Boa Fé advanced-stage gold project and the 11,000 acre Tabuaço advanced-stage tungsten project. Despite possessing one of the largest gold and tungsten positions in the entire country, the company still has an appetite for acquisitions. COLTF perpetually seeks out ways to improve their foundation with potentially promising advanced-stage opportunities. Boa Fé (Mentemor concession), approximately 60 miles east of Lisbon, has concluded Phase 1 infill drilling as of February which consisted of 32…

Continue Reading

TuesdayJun 17, 2014 4:52 pm

Global Payout, Inc. (GOHE) Steered by Experienced, Forward-Thinking Management

Headquartered in California, Global Payout provides customized and conventional mass payment solutions to organizations, businesses, corporations, and government agencies worldwide. Global Payout offers a comprehensive range of payment solutions for its user base, including a proprietary Consolidated Payment Gateway, prepaid debit card solutions (which include MasterCard, Visa, and Discover), and other customizable payment solutions. These payment solutions enable issuers to distribute funds and consumers with or without bank accounts to access and use funds on a global basis for payroll purposes, vendor payments, rebate collections, and general spending. Global Payout also enables its user base to transfer funds to bank…

Continue Reading

TuesdayJun 17, 2014 4:46 pm

Zenosense, Inc. (ZENO) Centered on Developing Detection Device to Ward-Off MRSA Cell Activity

Zenosense is looking at developing and marketing a device to be used in healthcare settings to detect the Methicillin-resistant Staphylococcus aureus (MRSA) “Super-Bug.” The company’s findings are grabbing the attention of the medical community as noted in many reputable publications. ScienceDaily, reporting on an article in The New England Journal of Medicine about a new highly-resistant MRSA bacterium, stated University of Texas Health Science Center’s international research team has identified a new superbug which has caused an infection in the bloodstream in a patient in Brazil. This case is the first reported bloodstream infection caused by a highly vancomycin-resistant MRSA…

Continue Reading

TuesdayJun 17, 2014 4:41 pm

India’s Desperate Power Situation Puts Human Life at Risk; Pan Global Corp. (PGLO) is Part of the Solution

India’s newly installed Prime Minister Narendra Modi is promising the country’s 1.26 billion people “round-the-clock power for all by 2022,” as originally reported by the Wall Street Journal. Nearly a fourth of the country’s population live in the dark – literally – with no access the nation’s overburdened electrical grid. Those that do have power often experience frequent blackouts. Prime Minister Modi is picking up where his predecessor failed, says India’s new energy Minister Piyush Goyal. “The previous government failed to take crucial decisions to expand grid connectivity,” Goyal told reporters last week. “The sector is in a mess.” What…

Continue Reading

TuesdayJun 17, 2014 1:37 pm

Innocent, Inc. (INCT) – An Oil & Gas Company Pursuing Technology-Driven Status

Innocent, Inc. is moving towards its long-term goal of creating a technology-driven North American oil and gas exploration and production company by concentrating, in the short term, on providing a steady balance sheet for its stakeholders. The company is vigilant about improvements in oil and gas production technologies because it anticipates using them to boost its production levels and to create predictable, lasting value. For now, the company is maintaining its focus on raising its production capacity through acquisitions and joint ventures. To reduce the risk involved in its oil and gas exploration activities, Innocent, Inc. is focusing on developing…

Continue Reading

TuesdayJun 17, 2014 9:59 am

Cal-Bay International, Inc. (CBYI) Receives $7 Million Funding Proposal for Launch of Marijuana Dispensary Card Payment Network

Today, Cal-Bay reported its reception of a $7 million capital funding proposal for a 3-year term note for its CB Green Card merchant processing system. The system will provide U.S.-based legal marijuana dispensaries with a credible channel for receiving purchase payments from their patients. Cal-Bay entered into a memorandum of understanding for the funding proposal, and the proposal’s terms will be fully disclosed once the definitive agreement is executed at close of Escrow. The proceeds will be used for completion of Cal-Bay’s Green Card merchant processing network as well as production of POS terminals required for use by the dispensaries.…

Continue Reading

TuesdayJun 17, 2014 9:09 am

International Stem Cell Corporation’s (ISCO) VP to Present at BIO 2014

International Stem Cell Corp., a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today that Executive Vice President Dr. Simon Craw will present an overview of the company and its subsidiaries at the BIO 2014 conference on Tuesday, June 24th at 4:15 pm PDT. The San Diego Convention Center is hosting the conference in the Mission Beach room. For additional conference details go to: http://convention.bio.org. Attracting approximately 15,000 of the most influential biotech and pharma participants from over 60 countries, BIO is the largest, most influential biotech meeting in the world. The convention is scheduled…

Continue Reading

MondayJun 16, 2014 10:00 am

VistaGen Therapeutics, Inc. (VSTA) Expands IP Portfolio, Awarded Canadian Patent Coverage

VistaGen Therapeutics, a biotech company using proprietary pluripotent stem cell technology for drug rescue and regenerative medicine, has received from the Canadian Intellectual Property Office a Notice of Allowance for Canadian patent No. 2,684,022, entitled "Mesoderm and Definitive Endoderm Cell Populations." This patent, which is exclusively licensed to VistaGen by the Icahn School of Medicine at Mount Sinai in New York, will expand VistaGen's intellectual property portfolio for pluripotent stem cell culture systems that produce human cells of the endoderm lineage, including liver, lung, pancreas, parathyroid and thyroid cells. The patent enables the company to extend its research into the…

Continue Reading

MondayJun 16, 2014 8:36 am

Raptor Resources Holdings Inc. (RRHI) Explores the Dodge Mine

Raptor Resources is in the mineral resource acquisition, exploration, development, production, and distri-bution business. Raptor Resources serves as the holding company for Mabwe Minerals, a natural resources and hard as-set company occupied with the mining, logistics, and sale of industrial minerals and metals. Raptor Re-sources owns 90 million shares, or approximately 64%, of Mabwe Minerals’ issued and outstanding shares of common stock, a notable share of the company. Raptor Resources and Mabwe Minerals are focused primarily on recovering barite and limestone from the Dodge Mine, which is based in Zimbabwe. In line with Raptor Resources’ other existing projects, which are…

Continue Reading

FridayJun 13, 2014 3:09 pm

VistaGen Therapeutics, Inc. (VSTA) Stands to Reverse Tremendous Costs of Drug Failure with Pluripotent Stem Cell Technology

For 16 years, California-based VistaGen Therapeutics has worked with key collaborators to develop proprietary technologies which produce several types of several types of mature, functional adult human cells for drug rescue application. In its drug rescue model, the company leverages its two biological assay systems, CardioSafe 3D™ and LiverSafe 3D™, and modern medicinal chemistry to generate novel, safer variants of once-promising drug candidates that were terminated due to unexpected heart or liver safety issues. In laymen’s terms, “drug rescue” refers to research and development efforts that use small molecule drug candidates that had been discovered and validated in medical efficacy…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered